Q32 Bio Inc.

This study tests a new drug called bempikibart (ADX-914) for people with severe alopecia areata, a condition that causes large patches of hair loss on the scalp. The trial has two parts: first, a placebo-controlled phase to see if the drug works, and second, an open-label phase w…